Gedeon Richter Areas of Expertise General Medicines
General Medicines
Neuropsychiatry Biotechnology Women's Healthcare General Medicines
Gedeon Richter has been enlarging its portfolio in the past 70 years with a wide range of generic medicines, playing a leading role in this field in Central-Eastern Europe and CIS countries. The General Medicines portfolio provides broad access to high quality and affordable medications, including traditional Richter drugs, generic and licensed-in innovative products and covering mainly cardiometabolic diseases, CNS and rheumatology therapeutic areas. Our over-the-counter (OTC) product range plays an important role in selected countries primarily in the cough&cold and pain segments.

The business goals include achieving regional significance in the cardiometabolic and CNS therapeutic areas in the largest Central and Eastern European markets in the coming years taking advantage of the current range of products and the planned expansion of the product range in the existing and new therapeutic areas. In addition, the General Medicines Business Unit intends to serve the patients with OTC medications.

In recent years, Richter placed a lot of emphasis on the development of generic and fixed-dose combined products in the existing and new therapeutic areas, which enables the strengthening of the cardiometabolic and CNS areas, among which diabetes, multiple sclerosis and blood therapeutic fields stand out. In the last 3 years, we went through process and capability developments to make sure that Richter can serve patients with generic alternatives on the first day after the expiry of patent exclusivity. 

Richter is committed to the development and supply of pharmaceuticals in a wide range of therapeutic areas, expanding to new geographies in order to improve access to affordable lifechanging treatments for patients worldwide.